Edesa Biotech, Inc.
- EDSA
- NASDAQ
- Biotechnology
- Inflammation/Immunology Biotech
- Monoclonal Antibodies
$2.78
Today +8.17%Quote Oct 19, 2026, 08:00 PM UTC
−32.85%over the last month
Max drawdown −39.0%From 1-month high −34.0%3 months −53.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Edesa Biotech
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
17
Market value
$26.8M
Quote Oct 19
Floor
$2.53
9.1% below price
Resistance
$2.88
3.7% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about EDSAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free